Form 4 for MRK Merck & Co.
Accepted 2022-02-28 00:00:00 ET · period of report 2022-02-24 · accession 0001127602-22-007023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-28 | 2022-02-24 | MRK | Litchfield Caroline | EVP, CFO | A - Grant | $73.51 | +2,429 | 26.6K | +10% | +$178.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-24 | A | A | 2,429 | $73.51 | 26,555.81 | D | — | — | (F1) Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/19. Performance shares were paid out at 140 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2021. (F2) Holdings include shares acquired in dividend reinvestment transactions. |